Advertisement
Screener

Amplify Weight Loss Drug & Treatment ETF (THNR) ETF Holdings

Add as a preferred source on Google

THNR ETF holdings

Amplify Weight Loss Drug & Treatment ETF (THNR). Weights reproduce the dated portfolio and may not sum to exactly 100% because of cash, derivatives, rounding, liabilities, or other positions. Provenance stays internal.

  • Fund: Reported value Amplify Weight Loss Drug & Treatment ETF.
  • Report date: Reported value 2025-06-30.
  • Reported holdings: Reported value 21.
  • SEC series ID: Reported value S000085024.
Snapshot fieldReported value
FundAmplify Weight Loss Drug & Treatment ETF
Report date2025-06-30
Reported holdings21
SEC series IDS000085024

Positions 1–21 of 21

TickerIssuerWeightValue (USD)Balance
LLYEli Lilly & Co12.5508169247%369,497.22474 NS
NVONovo Nordisk A/S11.1313153044%327,706.964,748 NS
REGNRegeneron Pharmaceuticals Inc7.0082998243%206,325393 NS
4519Chugai Pharmaceutical Co Ltd6.9012763859%203,174.223,900 NS
AMGNAmgen Inc6.5439636584%192,654.9690 NS
GILDGilead Sciences Inc4.7676961838%140,361.421,266 NS
AZNAstraZeneca PLC4.5906077498%135,147.921,934 NS
PFEPfizer Inc4.5820371248%134,895.65,565 NS
MRKMerck & Co Inc4.573734162%134,651.161,701 NS
ROGRoche Holding AG4.5539716566%134,069.35413 NS
ABBVAbbVie Inc4.5396051939%133,646.4720 NS
4507Shionogi & Co Ltd4.4529842045%131,096.277,300 NS
1801Innovent Biologics Inc4.070881474%119,847.1312,000 NS
AGPXXInvesco Government & Agency Po3.8941079168%114,642.9114,642.9 NS
HIMSHims & Hers Health Inc3.6828602839%108,423.752,175 NS
1093CSPC Pharmaceutical Group Ltd3.5983687035%105,936.31108,000 NS
ZEALZealand Pharma A/S2.3183459215%68,252.321,223 NS
VKTXViking Therapeutics Inc1.894780007%55,782.52,105 NS
CRNXCrinetics Pharmaceuticals Inc1.6372828602%48,201.761,676 NS
3933UNITED LAB1.1698590682%34,440.7618,000 NS
128940Hanmi Pharm Co Ltd0.8637798742%25,429.76120 NS

Similar ETFs

ETF NameCountryNet AssetsOverlap
Not available yet
Advertisement